These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33576189)

  • 1. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management.
    Ma J; Chen Q; Ma S
    J Cell Mol Med; 2021 Mar; 25(6):2764-2775. PubMed ID: 33576189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.
    Liu Y; Niu XH; Yin X; Liu YJ; Han C; Yang J; Huang X; Yu X; Gao L; Yang YZ; Xia YL; Li HH
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Goldberger JJ; Arora R; Green D; Greenland P; Lee DC; Lloyd-Jones DM; Markl M; Ng J; Shah SJ
    Circulation; 2015 Jul; 132(4):278-91. PubMed ID: 26216085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis.
    Lau DH; Linz D; Schotten U; Mahajan R; Sanders P; Kalman JM
    Heart Lung Circ; 2017 Sep; 26(9):887-893. PubMed ID: 28610723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI.
    Kuppahally SS; Akoum N; Burgon NS; Badger TJ; Kholmovski EG; Vijayakumar S; Rao SN; Blauer J; Fish EN; Dibella EV; Macleod RS; McGann C; Litwin SE; Marrouche NF
    Circ Cardiovasc Imaging; 2010 May; 3(3):231-9. PubMed ID: 20133512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
    Habibi M; Lima JA; Khurram IM; Zimmerman SL; Zipunnikov V; Fukumoto K; Spragg D; Ashikaga H; Rickard J; Marine JE; Calkins H; Nazarian S
    Circ Cardiovasc Imaging; 2015 Feb; 8(2):e002769. PubMed ID: 25652181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.
    den Uijl DW; Delgado V; Bertini M; Tops LF; Trines SA; van de Veire NR; Zeppenfeld K; Schalij MJ; Bax JJ
    Heart; 2011 Nov; 97(22):1847-51. PubMed ID: 21357370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation.
    Angel N; Li LI; Macleod RS; Marrouche N; Ranjan R; Dosdall DJ
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1352-60. PubMed ID: 26249367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation.
    Ling LH; McLellan AJ; Taylor AJ; Iles LM; Ellims AH; Kumar S; Teh A; Lee G; Wong MC; Azzopardi S; Sellenger MA; Morton JB; Kalman JM; Kistler PM
    Heart Rhythm; 2014 Sep; 11(9):1551-9. PubMed ID: 24931636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Bird's-Eye View of Left Atrial Myocardial Fibrosis in 121 Patients With Persistent Atrial Fibrillation: Developing Architecture and Main Cellular Players.
    Callegari S; Macchi E; Monaco R; Magnani L; Tafuni A; Croci S; Nicastro M; Garrapa V; Banchini A; Becchi G; Corradini E; Goldoni M; Rocchio F; Sala R; Benussi S; Ferrara D; Alfieri O; Corradi D
    Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e007588. PubMed ID: 32538131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
    Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
    JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review.
    Longobardo L; Todaro MC; Zito C; Piccione MC; Di Bella G; Oreto L; Khandheria BK; Carerj S
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):1-5. PubMed ID: 23798579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 Deficiency Induces Atrial Fibrosis and Increases Susceptibility to Atrial Fibrillation by the STAT3 Signaling Pathway.
    Zhang M; Wang H; Bie M; Wang X; Lu K; Xiao H
    J Cardiovasc Pharmacol; 2021 Aug; 78(2):175-183. PubMed ID: 34554674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial myofibroblast activation and connective tissue formation in a porcine model of atrial fibrillation and reduced left ventricular function.
    Lugenbiel P; Wenz F; Govorov K; Syren P; Katus HA; Thomas D
    Life Sci; 2017 Jul; 181():1-8. PubMed ID: 28546006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial strain: A useful index in atrial fibrillation.
    Cameli M; Mandoli GE; Loiacono F; Sparla S; Iardino E; Mondillo S
    Int J Cardiol; 2016 Oct; 220():208-13. PubMed ID: 27389443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Fibrotic Cell Type and Its Density on Atrial Fibrillation Dynamics: An In Silico Study.
    Palacio LC; Ugarte JP; Saiz J; Tobón C
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards.
    Quah JX; Dharmaprani D; Tiver K; Lahiri A; Hecker T; Perry R; Selvanayagam JB; Joseph MX; McGavigan A; Ganesan A
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1147-1160. PubMed ID: 33682258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.